 |
 |

April 3, 2002
JAMA. 2002;287:1735-1736.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
Parkinson Study Group
JAMA. 2002;287(13):1653-1661.
ABSTRACT
| FULL TEXT
-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
Mark A. Rubin, Ming Zhou, Saravana M. Dhanasekaran, Sooryanarayana Varambally, Terrence R. Barrette, Martin G. Sanda, Kenneth J. Pienta, Debashis Ghosh, and Arul M. Chinnaiyan
JAMA. 2002;287(13):1662-1670.
ABSTRACT
| FULL TEXT
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Jae-Hoon Kim, Steven J. Skates, Toshimitsu Uede, Kwong-kwok Wong, John O. Schorge, Colleen M. Feltmate, Ross S. Berkowitz, Daniel W. Cramer, and Samuel C. Mok
JAMA. 2002;287(13):1671-1679.
ABSTRACT
| FULL TEXT
Diuretic Therapy, the -Adducin Gene Variant, and the Risk of Myocardial Infarction or Stroke in Persons With Treated Hypertension
Bruce M. Psaty, Nicholas L. Smith, Susan R. Heckbert, Hans L. Vos, Rozenn N. Lemaitre, Alexander P. Reiner, David S. Siscovick, Joshua Bis, Thomas Lumley, W. T. Longstreth, Jr, and Frits R. Rosendaal
JAMA. 2002;287(13):1680-1689.
ABSTRACT
| FULL TEXT
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
Mitchell K. Higashi, David L. Veenstra, L. Midori Kondo, Ann K. Wittkowsky, Sengkeo L. Srinouanprachanh, Fred M. Farin, and Allan E. Rettie
JAMA. 2002;287(13):1690-1698.
ABSTRACT
| FULL TEXT
Nontypeable Haemophilus influenzae in Carriage and Disease: A Difference in IgA1 Protease Activity Levels
Srdjan Vitovski, Kim T. Dunkin, Anthony J. Howard, and Jon R. Sayers
JAMA. 2002;287(13):1699-1705.
ABSTRACT
| FULL TEXT
Effect of Leptin on Arterial Thrombosis Following Vascular Injury in Mice
Peter F. Bodary, Randal J. Westrick, Kevin J. Wickenheiser, Yuechen Shen, and Daniel T. Eitzman
JAMA. 2002;287(13):1706-1709.
ABSTRACT
| FULL TEXT
Mucosal Biofilm Formation on Middle-Ear Mucosa in the Chinchilla Model of Otitis Media
Garth D. Ehrlich, Richard Veeh, Xue Wang, J. William Costerton, Jay D. Hayes, Fen Ze Hu, Bernie J. Daigle, Miles D. Ehrlich, and J. Christopher Post
JAMA. 2002;287(13):1710-1715.
ABSTRACT
| FULL TEXT
|